Trial Parameters
Condition Wilson Disease
Sponsor Yale University
Study Type OBSERVATIONAL
Phase N/A
Enrollment 300
Sex ALL
Min Age N/A
Max Age N/A
Start Date 2017-12-18
Completion 2029-11-15
Brief Summary
The purpose of the registry/repository is to provide a mechanism to store data and specimens to support the conduct of future research about Wilson disease (WD). The overall aim is to determine the optimal testing for diagnosis and parameters for monitoring treatment of WD that will aid product utilization and development.
Eligibility Criteria
Inclusion Criteria: * Known diagnosis of WD * Able and willing to provide informed consent for adults (Parental/guardian permission (informed consent) and if appropriate, child assent for participants \<18 (or per local Institutional Review Board (IRB) regulation) Exclusion Criteria: * Diagnosis of WD has been excluded * Unwilling to provide informed consent or assent